Health Catalyst Inc (NASDAQ: HCAT) kicked off on Tuesday, up 3.83% from the previous trading day, before settling in for the closing price of $2.35. Over the past 52 weeks, HCAT has traded in a range of $2.02-$8.00.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 38.24%. While this was happening, its average annual earnings per share was recorded -27.03%. With a float of $66.16 million, this company’s outstanding shares have now reached $70.62 million.
Health Catalyst Inc (HCAT) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Health Information Services Industry. The insider ownership of Health Catalyst Inc is 6.46%, while institutional ownership is 78.16%. The most recent insider transaction that took place on Dec 05 ’25, was worth 72,328. In this transaction General Counsel of this company sold 27,425 shares at a rate of $2.64, taking the stock ownership to the 100,000 shares. Before that another transaction happened on Dec 04 ’25, when Company’s Director sold 47,997 for $2.67, making the entire transaction worth $128,349. This insider now owns 73,573 shares in total.
Health Catalyst Inc (HCAT) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported 0.04 earnings per share (EPS), lower than consensus estimate (set at 0.08) by -0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.08 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -27.03% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.19% during the next five years compared to 38.24% growth over the previous five years of trading.
Health Catalyst Inc (NASDAQ: HCAT) Trading Performance Indicators
Take a look at Health Catalyst Inc’s (HCAT) current performance indicators. Last quarter, stock had a quick ratio of 1.86. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.55.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.58, a number that is poised to hit 0.10 in the next quarter and is forecasted to reach 0.36 in one year’s time.
Technical Analysis of Health Catalyst Inc (HCAT)
The latest stats from [Health Catalyst Inc, HCAT] show that its last 5-days average volume of 0.72 million was superior to 0.71 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 11.33%.
During the past 100 days, Health Catalyst Inc’s (HCAT) raw stochastic average was set at 20.24%, which indicates a significant increase from 15.83% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.15 in the past 14 days, which was lower than the 0.20 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.79, while its 200-day Moving Average is $3.51. Now, the first resistance to watch is $2.47. This is followed by the second major resistance level at $2.51. The third major resistance level sits at $2.57. If the price goes on to break the first support level at $2.38, it is likely to go to the next support level at $2.32. Assuming the price breaks the second support level, the third support level stands at $2.28.
Health Catalyst Inc (NASDAQ: HCAT) Key Stats
The company with the Market Capitalisation of 172.59 million has total of 70,731K Shares Outstanding. Its annual sales at the moment are 306,580 K in contrast with the sum of -69,500 K annual income. Company’s last quarter sales were recorded 76,320 K and last quarter income was -22,230 K.
